Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06457152 · ClinicalTrials.gov registry record · NA
Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure
A NA study of Heart Failure, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 4
- Study locations
NCT06457152: Active NA study of Heart Failure, sponsored by NYU Langone Health.
NCT06457152 is a NA study of Heart Failure that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 3,000 participants, above the 2,041-participant average among 397 other Heart Failure trials with a reported enrollment target (47% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06457152, a NA study of Heart Failure, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study will test an automated, electronic health record (EHR-)embedded alert to improve prescribing of guideline-directed medical therapy for patients with heart failure and reduced ejection fraction (HFrEF). The investigators have previously tested and implemented this alert at NYU Langone Health (NYULH), and will now test and implement this alert across three other health systems.
Primary Outcome
Measured at the prescription encounter level using patient EHR data.
Conditions Studied
Interventions
- OTHER EHR-Emedded Alert
Study Locations (4)
Massachusetts
- University of Massachusetts - Boston
New York
- NYU Langone Health - New York
Ohio
- OhioHealth - Columbus
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2025-04-04 |
| Est. Completion | 2026-03-29 |
| Phase | NA |
What the registry record for NCT06457152 still lists
NCT06457152 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,041-participant average among 397 other Heart Failure trials with a reported enrollment target (47% higher).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which EHR-Emedded Alert is the first listed.
NCT06457152 reports a single indexed study location in Massachusetts, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT06457152 about?
NCT06457152 is a clinical study titled "Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure". This study will test an automated, electronic health record (EHR-)embedded alert to improve prescribing of guideline-directed medical therapy for patients with heart failure and reduced ejection fraction (HFrEF). The investigators have previously tested and implemented this alert at NYU Langone Heal...
What is the current status of trial NCT06457152?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2025-04-04. Estimated completion is 2026-03-29.
What conditions does trial NCT06457152 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT06457152?
The interventions under investigation include: EHR-Emedded Alert (OTHER).
Who is sponsoring clinical trial NCT06457152?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06457152 being conducted?
This trial has 4 study locations across Massachusetts, New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06457152's enrollment target sits among peer trials
3,000 35th of 397 higher than 362 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI